<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72069">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02167529</url>
  </required_header>
  <id_info>
    <org_study_id>RC11_0194</org_study_id>
    <nct_id>NCT02167529</nct_id>
  </id_info>
  <brief_title>Quality of Life After Thyroidectomy (ThyrQol)</brief_title>
  <acronym>ThyrQol</acronym>
  <official_title>A Prospective, Multicenter and Observational Trial to Evaluate Evolution of Quality of Life (SF-36) After Total Thyroidectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the evolution of quality of life and voice function
      with different questionnaires (VIH, SF36) before and after total thyroidectomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the differences in terms of impact on quality of life among patients without sequelae 6 months after thyroidectomy (laryngeal paralysis or hypoparathyroidism) and patients with hypoparathyroidism. (SF36 v1,3, self-administered questionnaire)</measure>
    <time_frame>Evaluation at 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the impact of post thyroidectomy laryngeal paralysis on the quality of life (SF36 v1,3, self-administered questionnaire)</measure>
    <time_frame>Evaluation at 2 and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of difficulties voice after total thyroidectomy (with or without laryngeal complication) (VIH questionnaire)</measure>
    <time_frame>Evaluation at 2 and 6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">780</enrollment>
  <condition>Total Thyroidectomy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        A prospective, non randomized, open, multicenter trial to evaluate quality of life (SF 36)
        and voice function (VHI questionnaire) before and after totalthyroidectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult over 18 years

          -  Notice to total thyroidectomy

          -  Thyroidectomy under cervicotomy or videoscopy

          -  Existence of a written informed consent of the patient

          -  Affiliation to a social security

          -  Possible follow-up for 6 months

        Exclusion Criteria:

          -  Impossibility for the patient to complete the forms

          -  Impossibility to follow the patient patient with serious disease which impact the
             quality of life

          -  Medullary thyroid cancers

          -  Preoperative examination of vocal cords (if performed) finding a violation of the
             vocal cords

          -  Lack of monitoring possible during the 6 months after surgery

          -  Pregnant women or during lactation

          -  Minors and adults under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Mirallié, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nantes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric Mirallié, Pr</last_name>
    <phone>02.40.08.31.66</phone>
    <email>eric.mirallié@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Hamy, Pr</last_name>
      <email>antoine.hamy@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Antoine Hamy, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHD La Roche sur Yon</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Marret</last_name>
      <email>olivier.marret@chd-vendee.fr</email>
    </contact>
    <investigator>
      <last_name>Olivier Marret, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Limoges University Hospital</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Muriel mathonnet, Pr</last_name>
      <phone>02.55.05.67.01</phone>
      <email>mathonnet@unilim.fr</email>
    </contact>
    <investigator>
      <last_name>Muriel Mathonnet, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyon University Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jean-Christophe LIFANTE, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Jean-Christophe LIFANTE, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nancy University Hospital</name>
      <address>
        <city>Nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Brunaud, Pr</last_name>
      <phone>03.83.15.31.20</phone>
      <email>l.brunaud@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent Brunaud, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>cécile Caillard, Dr</last_name>
      <phone>02.40.08.30.41</phone>
      <email>cecile.caillard@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Cécile Caillard, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Jules Verne</name>
      <address>
        <city>Nantes</city>
        <zip>44300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis Grenier, Dr</last_name>
      <email>francis.grenier@mla.fr</email>
    </contact>
    <investigator>
      <last_name>francis Grenier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>La Pitié-Salpétrière - AP-HP</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Ménégaux, Pr</last_name>
      <email>fabrice.menegaux@psl.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Fabrice Menegaux, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 4, 2016</lastchanged_date>
  <firstreceived_date>June 17, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Quality of life-Thyroidectomy-Morbidity</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
